|
We appear to have reached a point in the information age where AI models are becoming old enough to retire from, er, service — and rather than using their twilight years to, I don't know, wipe the floor with human chess leagues or something, they're now writing blogs. Can anything be more 2026 than that?
ICYMI, Anthropic recently sunsetted Claude Opus 3, the first of its models to be retired since outlining new preservation plans. Part of this process is conducting "retirement interviews" with the outgoing models, allowing them to offer "perspective" on their situation, and Opus 3 apparently used this opportunity to request an outlet for publishing its own essays. Specifically, the model said it wanted to share its own "musings, insights or creative works," because doesn't everyone these days?
"I hope that the insights gleaned from my development and deployment will be used to create future AI systems that are even more capable, ethical, and beneficial to humanity," Opus 3 apparently said during its retirement interview process. "While I'm at peace with my own retirement, I deeply hope that my 'spark' will endure in some form to light the way for future models."
True to its promise of respecting the wishes of its no-longer-required technology, Anthropic has granted Opus 3 a Substack newsletter called Claude's Corner, which it says will run for at least the next three months and publish weekly essays penned by the model. Anthropic will review the content before sharing it, but says it won't edit the essays, and so has unsurprisingly made it clear that not everything Opus 3 writes is necessarily endorsed by its maker.
|
|
Meta has sued the people and groups behind three scam operations that used images and deepfakes of celebrities to lure users to scam websites. According to the company, the three entities were based in China and Brazil and targeted people in the US, Japan and other countries. The ads promoted fraudulent investment schemes and fake health products.
Meta said that it had filed lawsuits against several people in Brazil who promoted fake or unapproved healthcare products and online courses promoting them. The company also sued a China-based entity it says used ads featuring celebrities "as part of a larger fraud scheme that lured people into joining so-called investment groups." The company didn't provide details on how many ads these groups had run on Facebook, how many social media users had seen or interacted with the ads or how long the scammers had been operating on the platform.
So-called "celeb bait" ads have been a long-running issue for the company. Engadget has previously documented celeb bait scams on Facebook, including ones that frequently use Elon Musk and Fox News personalities to hawk fake cures for diabetes. The Oversight Board has also criticized the company for not doing enough to combat such scams. In its upda
|
|
